Li Zhou

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP.

Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP.

Journal: Cellular & molecular immunology

Published: September 07, 2025

Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies.

Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: August 24, 2025

Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system.

Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system.

Journal: Trends in biotechnology

Published: July 02, 2025

NAMPT Modulates Gemcitabine Resistance in Pancreatic Cancer via the p53 Signaling Pathway.

NAMPT Modulates Gemcitabine Resistance in Pancreatic Cancer via the p53 Signaling Pathway.

Journal: Pancreas

Published: September 25, 2024

Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells.

Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells.

Journal: Molecular cell

Published: August 27, 2024

Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis.

Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis.

Journal: Cancer letters

Published: July 16, 2024

NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression.

NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression.

Journal: Cell reports

Published: June 15, 2024

MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C.

MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: December 10, 2023

An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection.

An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection.

Journal: Future oncology (London, England)

Published: July 21, 2022

FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Journal: Pancreas

Published: July 20, 2022

Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Metalloproteinase 9 in Resectable Pancreatic Ductal Adenocarcinoma.

Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Metalloproteinase 9 in Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Pancreas

Published: October 29, 2021

Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion.

Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: August 05, 2020

Showing 1-12 of 60

Last Updated: 09/26/2026